Care of pediatric oncology patients after continuous hyperthermic peritoneal perfusion.
Mauricio
Riza V
RV
Children's Cancer Hospital of the University of Texas M.D. Anderson Cancer Center, Houston, 77030, USA. rmauricio@mdanderson.org
Green
Holly
H
Hayes-Jordan
Andrea
A
D000293:Adolescent; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002277:Carcinoma / Q000451:nursing / Q000556:secondary / Q000628:therapy*; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000009:adverse effects / Q000451:nursing*; D002648:Child; D002945:Cisplatin / Q000008:administration & dosage; D004487:Edema / Q000209:etiology / Q000451:nursing; D006801:Humans; D006979:Hyperthermia, Induced / Q000009:adverse effects / Q000451:nursing*; D008297:Male; D010534:Peritoneal Neoplasms / Q000451:nursing / Q000556:secondary / Q000628:therapy*; D018228:Sarcoma, Small Cell / Q000451:nursing / Q000556:secondary / Q000628:therapy*; D014883:Water-Electrolyte Imbalance / Q000209:etiology / Q000451:nursing
D000970:Antineoplastic Agents; D002945:Cisplatin